Is Sabra Health Care REIT (SBRA) Still Worth Its 93% Run?

Sabra Health Care REIT has delivered a strong run over the past five years, yet current valuation checks suggest the stock now leans expensive rather than a clear bargain.

• Over the past 5 years, Sabra Health Care REIT has returned about 93%, which puts recent gains front and centre when considering what is already priced in.
• The real estate trust’s future value can hinge on how reliably its tenants convert rent into cash and on how well its own balance sheet holds up against interest costs and funding needs.
• On a broad set of valuation checks, Sabra Health Care REIT scores 2 out of 6, which points to a stock that screens as relatively expensive instead of obviously cheap on these metrics.

The key question now is whether Sabra Health Care REIT’s current share price already reflects most of the past return and the main risks to its cash flows, or if the valuation still leaves room for further upside.

Find context for Sabra Health Care REIT’s 5 year, 93% run by scanning a hand picked set of 31 high quality undervalued stocks that still screen as relatively cheap on key fundamentals.

Has Sabra Health Care REIT Run Too Far on Earnings?

P/E works reasonably well for Sabra Health Care REIT because investors watch reported earnings closely alongside cash flow when assessing listed real estate trusts. On that yardstick, the stock changes hands at about 80.1x earnings, which is more than double the peer average of roughly 39.2x and far above the broader Health Care REITs sector on 17.1x.

The fair P/E ratio from the model is 48.9x, which already builds in the company’s specific risk profile and sector traits. Compared with that benchmark, Sabra Health Care REIT trades at a steep premium, suggesting the market is paying a high price for each dollar of earnings relative to what those fundamentals might justify.

On this P/E measure, Sabra Health Care REIT currently screens as overvalued, with its share price already implying a rich earnings multiple.

See what the numbers say about this price — find out in our valuation breakdown.

The Sabra Health Care REIT Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Sabra Health Care REIT pick up where the valuation puzzle leaves off and explain which future paths for growth, profitability, and earnings would need to hold for the stock to end up worth meaningfully more or less than today’s price. Each one presents Sabra Health Care REIT's implied fair value as a thesis about the business that you can keep checking over time, and they are available on the Community page.

Share a narrative on Sabra Health Care REIT with a number-driven view on its growth, margins and execution outlook from here, and be one of the first voices in the Simply Wall St community to track how that thesis holds up as new figures arrive.

Do you think there's more to the story for Sabra Health Care REIT? Head over to our Community to see what others are saying!

The Bottom Line

Sabra Health Care REIT now screens as overvalued on earnings multiples, with the market already attaching a full price to its current profit profile. Broader valuation checks skew cautious rather than supportive, so the main question is whether that premium holds or if expectations cool. What matters most from here is whether Sabra’s tenants keep rent flowing predictably enough for investors to stay comfortable paying such a high P/E for those earnings.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com